Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RL✓SelectedUSD · RLGSK vs RL performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs RL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.3%
RL return
+250.5%
Excess return
-185.2%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioRLExcessAlpha
1D+0.5%-1.2%+1.7%+0.6%
7D+1.1%+2.6%-1.4%+1.0%
30D+6.3%+2.9%+3.4%+6.2%
3M+1.8%0.0%+1.8%+1.8%
6M+1.7%+17.1%-15.5%+1.1%
YTD+6.5%+10.1%-3.6%+6.1%
1Y+9.5%+17.3%-7.8%+9.0%
3Y+65.3%+249.3%-184.0%+61.5%
All+65.3%+250.5%-185.2%+61.5%

Cumulative growth

Daily Returns

Daily percentage return beside RL.

Daily Out/Under-Performance

Portfolio return minus RL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded RL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling